Dynavax Technologies Corporation Appoints Joseph Metzinger as Chief Accounting Officer

Dynavax Technologies Corporation, a biopharmaceutical company based in Emeryville, California, has appointed Joseph Metzinger as its new Chief Accounting Officer, effective May 12, 2025. Metzinger, a seasoned financial executive with 19 years of leadership experience, brings a wealth of knowledge and expertise to the role. He will be responsible for overseeing the company's accounting and finance functions and serving as the principal accounting officer. Metzinger joins Dynavax from CFGI, a global accounting and business advisory firm, where he served as Chief Accounting Officer and controller for a publicly traded biotechnology company.

Key Takeaways:

  • Joseph Metzinger, a 41-year-old financial executive, was appointed as Dynavax Technologies Corporation's Chief Accounting Officer, effective May 12, 2025.
  • Metzinger has 19 years of leadership experience, including serving as Chief Accounting Officer and controller for a publicly traded biotechnology company at CFGI.
  • He will receive an annual base salary of $315,000 and is eligible for an annual discretionary performance bonus of up to 40% of his then-current base salary.
  • Metzinger will be granted an award of 38,182 restricted stock units and 31,500 stock options pursuant to the Company's 2018 Equity Incentive Plan.
  • The company intends to enter into its standard form of indemnification agreement with Metzinger, which was previously filed by the company as Exhibit 10.1 to its Quarterly Report on Form 10-Q filed with the SEC on November 7, 2019.
  • Dynavax will also enter into its standard form of Management Continuity and Severance Agreement ("MCSA") with Metzinger, which was previously filed by the company as Exhibit 10.3 to its Quarterly Report on Form 10-Q filed on August 3, 2023.

Statistics:

  • Annual base salary for Joseph Metzinger: $315,000
  • Annual discretionary performance bonus eligible for Joseph Metzinger: up to 40% of his then-current base salary
  • Total restricted stock units granted to Joseph Metzinger: 38,182
  • Total stock options granted to Joseph Metzinger: 31,500

Sources:

  • UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549
  • Filed 10-Q Quarterly Report on Form 10-Q filed with the SEC on November 7, 2019
  • Filed 10-Q Quarterly Report on Form 10-Q filed on August 3, 2023